Реакция #67017

ord-efa467241a014c2792c90b7b67af5d2f

Растворители

Условия реакции

Подробные условия
See reaction.notes.procedure_details.

Обработка

  1. 1
    ДругоеThe solvent and the excess reagent are removed under reduced pressure
  2. 2
    workup.DISSOLUTIONThe solid residue is again dissolved in dichloromethane and, at 0° C.
  3. 3
    workup.STIRRINGThe reaction mixture is stirred at room temperature overnight
  4. 4
    Другоеthe aqueous phase is removed
  5. 5
    Экстракцияextracted with ethyl acetate
  6. 6
    СушкаThe combined organic phases are dried over sodium sulphate
  7. 7
    Концентрированиеconcentrated
  8. 8
    ДругоеPurification by column chromatography

Методика

To a solution of [3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]acetic acid (177 mg) in dichloromethane (40 ml) are added, at 0° C., oxalyl chloride (290 mg) and one drop of N,N-dimethylformamide. The reaction mixture is stirred at room temperature for 2 hours. The solvent and the excess reagent are removed under reduced pressure. The solid residue is again dissolved in dichloromethane and, at 0° C., added dropwise to a solution of 4-{4-[5-(2-chloro-6-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidinium chloride and triethylamine (5.0 eq.) in dichloromethane (25 ml). The reaction mixture is stirred at room temperature overnight. Then it is admixed with concentrated sodium hydrogencarbonate solution, and the aqueous phase is removed and extracted with ethyl acetate. The combined organic phases are dried over sodium sulphate and concentrated. Purification by column chromatography gives 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[5-(2-chloro-6-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone (110 mg).

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US08524743B2uspto-grants-2013_09